MDMA therapy for PTSD in young adults with childhood trauma
Part of Mental health clinical trials.
This study tests whether MDMA, when combined with therapy, can help young adults with post-traumatic stress disorder (PTSD) that started after childhood trauma. The goal is to see if this treatment can reduce PTSD symptoms and improve well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 26 years old.
- You have been diagnosed with PTSD, and the trauma happened during childhood.
- You are able to attend therapy sessions and stay overnight with a trusted adult after each treatment session.
- You are willing to stop taking psychiatric medications during the study.
- You have a regular mental health provider who can resume your care after the study.
- You live in the United States and can communicate in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
This study tests whether MDMA, given in a controlled clinical setting, can reduce symptoms of PTSD and alcohol use disorder in veterans. It also combines the medication with structured therapy sessions to help you manage symptoms without relying on alcohol or other substances.
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
This Phase 2 study tests whether MDMA combined with therapy that uses exposure (gradual confronting of trauma memories) can reduce PTSD symptoms. It may help people who meet PTSD criteria, can follow strict safety rules, and can complete medicine-session monitoring.
This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.
Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.